Perimenopause Absenteeism Linked to Workplace Culture and Ageism, AMY Study Shows

Key facts

On October 4, 2026, Dr. Jen Gunter’s health publication *The Vajenda* detailed findings from the AMY Study, an investigation examining how the perimenopausal transition affects individuals in professional settings. The study focused on health-related absenteeism, which was assessed by evaluating whether respondents had missed work for health reasons within the preceding seven days.

According to reporting by *The Vajenda*, the AMY Study examined the broader context in which midlife health issues manifest in the labor force. The research highlighted that an employee's ability to maintain regular work attendance is influenced not only by direct perimenopausal symptoms but also by co-occurring health conditions. Furthermore, the analysis emphasized that organizational culture plays a pivotal role in how health symptoms affect job performance and attendance.

The study identified ageism and workplace mistreatment as significant factors that exacerbate the burden on perimenopausal employees. Rather than encountering supportive management or flexible working conditions, midlife workers frequently report experiencing negative attitudes or unfair assumptions regarding their competence and commitment. The reporting noted that when health-related absences occur, they take place within workplace dynamics where employees may fear professional penalty or marginalization due to combined age and gender biases.

Why it matters

The intersection of perimenopause and workplace performance carries substantial implications for labor market participation, organizational productivity, and gender equity in senior employment ranks. Women aged 40 to 55 represent a core demographic within the global workforce, often occupying management, executive, or highly specialized professional positions acquired over decades of experience. When perimenopausal symptoms interact with unsupportive work environments, the resulting absenteeism and reduced productivity can impair career progression and long-term financial security.

From an economic perspective, health-related absenteeism during midlife contributes to measurable losses in organizational capacity and increased turnover costs. When workplaces fail to accommodate midlife health transitions, experienced workers may choose to reduce their working hours, step down from leadership tracks, or exit the labor force entirely. This premature departure accelerates the loss of institutional knowledge and widens gender gaps in senior leadership and pension accumulation.

Moreover, the compounding effects of ageism and mistreatment create legal and administrative challenges for employers. Organizations that fail to address gendered ageism or fail to provide reasonable health accommodations risk non-compliance with statutory workplace standards and labor protections. Addressing perimenopause in occupational health policy is increasingly recognized not as an isolated wellness initiative, but as a structural component of workforce retention, risk management, and diversity strategies.

Perimenopause is the physiological phase preceding menopause during which the ovaries gradually decline in function. Characterized by erratic fluctuations in estrogen and progesterone, perimenopause typically begins in a woman's 40s—though it can start earlier—and spans anywhere from four to eight years before reaching menopause, defined clinically as 12 consecutive months without a menstrual period. Symptoms during this phase vary widely in intensity and duration, encompassing vasomotor symptoms like hot flashes and night sweats, sleep disruptions, mood changes, joint pain, heavy bleeding, and cognitive changes frequently described as brain fog.

Historically, occupational health and medicine focused primarily on acute injuries, toxicological exposures, and pregnancy-related accommodations, largely omitting midlife reproductive health transitions from workplace policy. For decades, menopausal and perimenopausal symptoms were treated as private medical issues to be managed individually without institutional modification of work environments, hours, or thermal comfort controls.

Over the past decade, academic researchers, occupational health professionals, and advocacy groups have increasingly examined the economic cost of menopausal health transitions. In jurisdictions such as the United Kingdom, legislative committees and labor trade unions have conducted inquiries into midlife employment retention, finding that thousands of women reduce hours or resign due to unmanaged symptoms combined with rigid workplace cultures. Similar research initiatives across Europe and North America have sought to quantify how workplace accommodations—such as flexible scheduling, remote work options, temperature controls, and supportive sick leave policies—can mitigate absenteeism and support employee retention.

At the same time, socio-legal research has highlighted the phenomenon of gendered ageism, wherein midlife and older women face compound discrimination based on age and gender. Unlike younger employees or male peers, midlife women reporting health challenges may confront harmful stereotypes regarding cognitive decline or declining professional value, discouraging open communication with supervisors about health-related leave needs.

Reaction

The publication of the AMY Study findings by *The Vajenda* reflects growing engagement among medical communicators and occupational health specialists regarding midlife healthcare at work. Medical practitioners specializing in menopause management have long advocated for broader clinical and public recognition of perimenopause, emphasizing that workplace accommodation is a critical determinant of patient well-being and treatment efficacy.

Corporate human resource professionals and labor advocates are expected to review such study findings as part of an ongoing debate regarding formal workplace menopause policies. While some international corporations and public-sector employers have established explicit menopause and perimenopause guidelines, many organizations have not implemented formalized policies. Trade unions and employee advocacy networks frequently urge employers to integrate midlife health protections into standard equality, diversity, and health-and-safety frameworks.

Official responses from regulatory health agencies and employment policy bodies regarding the AMY Study's specific parameters remain focused on evaluating evidence-based accommodations. Labor analysts emphasize that practical adjustments, rather than passive policies, are essential to reducing absenteeism and protecting midlife employees from discriminatory practices.

What we don't know yet

While the summary provided by *The Vajenda* establishes key themes from the AMY Study, several specific quantitative details remain unstated. The available reporting does not specify the total number of participants enrolled in the study cohort, nor does it detail the geographic distribution or occupational sectors represented among the respondents.

Additionally, the exact percentage of missed work hours or calculated monetary costs associated with the observed seven-day absenteeism metric are not detailed in the summary. It is also unclear to what extent study participants had access to healthcare management, such as hormone therapy or non-hormonal clinical treatments, and whether access to such medical care altered absenteeism patterns. Furthermore, the report leaves open how frequently instances of ageism or workplace mistreatment resulted in formal human resources complaints or legal claims under existing labor legislation.

What to watch

In the coming months, observers will monitor whether full, peer-reviewed datasets from the AMY Study are published in academic medical or public health journals, which would provide comprehensive statistical breakdowns of the cohort. Occupational health organizations and clinical bodies, such as The Menopause Society and the International Menopause Society, will likely review the data to refine clinical guidance on work-related symptom management.

At the institutional level, researchers will watch for policy shifts within corporate HR departments and government agencies, specifically regarding the adoption of formal midlife health leave provisions and flexible work arrangements. Legislative committees handling labor and equality standards in various countries may also reference emerging perimenopause study data during upcoming policy reviews on midlife labor retention and anti-discrimination legislation.

***

This report is based on reporting published by The Vajenda on October 4, 2026, summarizing findings from the AMY Study on perimenopause, health-related absenteeism, and workplace environment factors.